Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide Injection

The purpose of this study is to identify the risk factors for a recurrence or persistence of diabetic macular oedema (DME) after a sub-Tenon’s capsule triamcinolone acetonide (STTA) injection. The medical records of 124 patients (124 eyes) treated by STTA were reviewed. The age, sex, HbA1c level, be...

Full description

Saved in:
Bibliographic Details
Main Authors: Toshiyuki Oshitari, Yuta Kitamura, Sakiko Nonomura, Miyuki Arai, Yoko Takatsuna, Eiju Sato, Takayuki Baba, Shuichi Yamamoto
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2015/195737
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559382591700992
author Toshiyuki Oshitari
Yuta Kitamura
Sakiko Nonomura
Miyuki Arai
Yoko Takatsuna
Eiju Sato
Takayuki Baba
Shuichi Yamamoto
author_facet Toshiyuki Oshitari
Yuta Kitamura
Sakiko Nonomura
Miyuki Arai
Yoko Takatsuna
Eiju Sato
Takayuki Baba
Shuichi Yamamoto
author_sort Toshiyuki Oshitari
collection DOAJ
description The purpose of this study is to identify the risk factors for a recurrence or persistence of diabetic macular oedema (DME) after a sub-Tenon’s capsule triamcinolone acetonide (STTA) injection. The medical records of 124 patients (124 eyes) treated by STTA were reviewed. The age, sex, HbA1c level, best-corrected visual acuity, central macular thickness, insulin use, pioglitazone use, systemic hypertension, serous retinal detachment, proteinuria, panretinal photocoagulation, microaneurysm photocoagulation (MAPC), subthreshold micropulse diode laser photocoagulation (SMDLP), cataract surgery, and history of vitrectomy were examined by logistic regression analysis. Procedures of MAPC and SMDLP were significantly associated with DME treated with STTA (P=0.0315, P=0.04, resp.). However, a history of vitrectomy was found to have significantly fewer recurrences or persistent DME after STTA (P=0.0464). In conclusion, patients who required combined MAPC or SMDLP with a STTA injection had significantly higher refractoriness to STTA, but postvitrectomy may prevent the recurrence or persistence of DME after STTA injection.
format Article
id doaj-art-e316311b84b749ffb265743f9f97049b
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-e316311b84b749ffb265743f9f97049b2025-02-03T01:30:12ZengWileyJournal of Ophthalmology2090-004X2090-00582015-01-01201510.1155/2015/195737195737Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide InjectionToshiyuki Oshitari0Yuta Kitamura1Sakiko Nonomura2Miyuki Arai3Yoko Takatsuna4Eiju Sato5Takayuki Baba6Shuichi Yamamoto7Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba Prefecture, Chiba 260-8670, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba Prefecture, Chiba 260-8670, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba Prefecture, Chiba 260-8670, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba Prefecture, Chiba 260-8670, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba Prefecture, Chiba 260-8670, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba Prefecture, Chiba 260-8670, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba Prefecture, Chiba 260-8670, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba Prefecture, Chiba 260-8670, JapanThe purpose of this study is to identify the risk factors for a recurrence or persistence of diabetic macular oedema (DME) after a sub-Tenon’s capsule triamcinolone acetonide (STTA) injection. The medical records of 124 patients (124 eyes) treated by STTA were reviewed. The age, sex, HbA1c level, best-corrected visual acuity, central macular thickness, insulin use, pioglitazone use, systemic hypertension, serous retinal detachment, proteinuria, panretinal photocoagulation, microaneurysm photocoagulation (MAPC), subthreshold micropulse diode laser photocoagulation (SMDLP), cataract surgery, and history of vitrectomy were examined by logistic regression analysis. Procedures of MAPC and SMDLP were significantly associated with DME treated with STTA (P=0.0315, P=0.04, resp.). However, a history of vitrectomy was found to have significantly fewer recurrences or persistent DME after STTA (P=0.0464). In conclusion, patients who required combined MAPC or SMDLP with a STTA injection had significantly higher refractoriness to STTA, but postvitrectomy may prevent the recurrence or persistence of DME after STTA injection.http://dx.doi.org/10.1155/2015/195737
spellingShingle Toshiyuki Oshitari
Yuta Kitamura
Sakiko Nonomura
Miyuki Arai
Yoko Takatsuna
Eiju Sato
Takayuki Baba
Shuichi Yamamoto
Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide Injection
Journal of Ophthalmology
title Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide Injection
title_full Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide Injection
title_fullStr Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide Injection
title_full_unstemmed Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide Injection
title_short Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide Injection
title_sort risk factors for refractory diabetic macular oedema after sub tenon s capsule triamcinolone acetonide injection
url http://dx.doi.org/10.1155/2015/195737
work_keys_str_mv AT toshiyukioshitari riskfactorsforrefractorydiabeticmacularoedemaaftersubtenonscapsuletriamcinoloneacetonideinjection
AT yutakitamura riskfactorsforrefractorydiabeticmacularoedemaaftersubtenonscapsuletriamcinoloneacetonideinjection
AT sakikononomura riskfactorsforrefractorydiabeticmacularoedemaaftersubtenonscapsuletriamcinoloneacetonideinjection
AT miyukiarai riskfactorsforrefractorydiabeticmacularoedemaaftersubtenonscapsuletriamcinoloneacetonideinjection
AT yokotakatsuna riskfactorsforrefractorydiabeticmacularoedemaaftersubtenonscapsuletriamcinoloneacetonideinjection
AT eijusato riskfactorsforrefractorydiabeticmacularoedemaaftersubtenonscapsuletriamcinoloneacetonideinjection
AT takayukibaba riskfactorsforrefractorydiabeticmacularoedemaaftersubtenonscapsuletriamcinoloneacetonideinjection
AT shuichiyamamoto riskfactorsforrefractorydiabeticmacularoedemaaftersubtenonscapsuletriamcinoloneacetonideinjection